# Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis

> **NCT05990959** · — · UNKNOWN · sponsor: **China Medical University Hospital** · enrollment: 800 (estimated)

## Conditions studied

- Hepatocellular Carcinoma Recurrent
- Surgery

## Interventions

- **OTHER:** No intervention for research purpose

## Key facts

- **NCT ID:** NCT05990959
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-22
- **Primary completion:** 2025-12
- **Final completion:** 2025-12-31
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2023-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05990959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05990959, "Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05990959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*